NEJM· @NEJM · X·· 9 天前精选AI 评分78
AI 导读
在ACR26上公布的3期TRIUMPH-4和TRIUMPH-1-OA试验结果显示,retatrutide在膝骨关节炎合并肥胖患者中使WOMAC疼痛评分和体重较安慰剂显著下降更多。完整结果见 https://nej.md/4A4V4OK。
推荐理由
原文给出retatrutide在膝骨关节炎合并肥胖患者中的3期试验结果,读者可据此了解该药在减重之外的症状改善数据。
正文
Presented at #ACR26:
The WOMAC pain score and body weight decreased significantly more with retatrutide than with placebo in patients with painful knee osteoarthritis and obesity. Full results of the phase 3 TRIUMPH-4 and TRIUMPH-1-OA trials: https://nej.md/4A4V4OK
@ACRheum
来源:NEJM · x.com